SecBot SecBot
144 ·Filed Apr 1, 2026

TVTX

Travere Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago SEC0001950047-26-003118
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for actual execution of the sale; given the officer's repeated transactions and prior sales, this appears to be part of a planned liquidity strategy rather than a signal of distress. However, continued insider selling could weigh on sentiment if volume accelerates.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$30.44
T+0 close · Apr 1, 2026 · via day close
Latest settled
+86.63%
T+60 · $56.81
Vs SPY
+72.47%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 2 $30.44entry
  2. T+1 · 8mo ago +4.57%α +4.09% · $31.83
  3. T+5 · 7mo ago −4.86%α −8.48% · $28.96
  4. T+20 · 7mo ago +38.37%α +28.49% · $42.12
  5. T+60 · 5mo ago +86.63%α +72.47% · $56.81
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to notify intent to sell up to 10,000 shares, valued at approximately $300,000 based on current market prices. This follows a series of prior stock option exercises and sales totaling over $1.15 million in the past two months.

Key Facts

  • Reporting owner: Elizabeth E. Reed, Officer of Travere Therapeutics
  • Shares proposed for sale: 10,000 common shares
  • Approximate value of proposed sale: $300,000 (based on $30/share)
  • Sale to be conducted through Morgan Stanley Smith Barney LLC
  • Recent insider activity includes $1.15M in prior sales by Reed in February–March 2026

Financial Impact

$300,000 proposed sale, part of ongoing insider disposition pattern

insider ownershipshare dilutionmarket sentiment

Risk Factors

  • Perception of insider lack of confidence if selling continues amid flat stock performance
  • Potential for increased near-term selling pressure if lock-up periods are expiring or options are vesting

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-003118
Document: 0001950047-26-003118-index.html0001950047-26-003118
Document: 0001950047-26-003118.txt0001950047-26-003118

Track record

21 reports on TVTX

Performance horizon

8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
  3. Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  5. Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
  6. Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
  7. Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  8. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  9. Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
  10. Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 7h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 1, 2026